Contact us on +44 (0)1270 270010 | info@boydconsultants.com

Early drug development – key considerations to maximise success

Early drug development – key considerations to maximise success
January 31, 2020 SueCarr

Boyds is hosting a half-day workshop focusing on early drug development.

Early development activities can be complex and this interactive half-day session will help you understand the do’s and don’ts when planning your CTA/IND programme. Our team of regulatory professionals will focus on aligning development and regulatory activities and the importance of integrated development plans, helping achieve accelerated development in Europe and the US.

 

Date: 19 March 2020
Venue: The Cambridge Building, Babraham Research Campus, Cambridge
Cost: £175 +VAT

 

Agenda:

1.00pm Registration and refreshments

1.30pm Introduction to Boyds

1.45pm Nonclinical development programmes to support first-in-human studies

2.30pm Preparing clinical trial applications for Europe and the US

3.30pm Refreshments and networking

3.45pm Using clinical data to maximise regulatory value

4.45pm Close

The workshop will be delivered by experienced members of the Boyds team.

 

Email julie.hollowell@boydconsultants.com or phone 01270 270010 to book your place. Please register by 11 March 2020.